Press "Enter" to skip to content

Apollo Pharmacy temporarily suspends sale of Ranbaxy drugs

New Delhi: Apollo Pharmacy, a division of Apollo Hospitals Enterprise and the country’s largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured by Ranbaxy Laboratories. The hospital, however, has not issued any separate advisory to its doctors.

“Our medical committee, which is a very strong committee within Apollo, has reviewed the matter and recommended, as a cautionary measure, we should temporarily suspend sale of Ranbaxy medicines, as we cannot take a chance with patients’ safety,” said Shobana Kamineni, executive director, Apollo Hospitals.

“We have nothing against Ranbaxy but we must respect what our medical committee has ordered… We have asked them (Ranbaxy) to re-certify whatever stocks we have till now,” Kamineni said, adding Apollo Pharmacy would restart sale of Ranbaxy drugs after the company had fulfilled the requirements and satisfied the medical committee. [Source: Business Standard]

Update

“We haven’t suspended the (Ranbaxy) drugs per se, but our medical oversight committee has asked for FDA and Good Manufacturing Practices (GMP) certificate for medicines that we dispense,” said Kamineni.

According to some Apollo Pharmacy outlets in Delhi and Mumbai, an instruction to stop selling Ranbaxy drugs did come on Friday morning but was withdrawn by afternoon. [Source: ET]

Related Stories

PIL filed against Ranbaxy for allegedly selling adulterated drugs in India

Debate: Should hospitals ban Ranbaxy drugs?

IMA plans to ask DCGI to probe quality of Ranbaxy’s drugs

Jaslok Hospital advises doctors against prescribing Ranbaxy drugs

Ranbaxy to pay $500 million to settle US fraud charges

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *